Arnaud Garnier
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Real-Life Data of 2-Year Lumasiran Use in the DAILY-LUMA Cohort.
Journal: Kidney international reports
Published: November 30, 2024
"L'étudiant expert", a podcast for student nurses
Journal: Revue de l'infirmiere
Published: April 21, 2024
Authors' Reply: Eculizumab Seems to be a Life Saver Even in Shiga Toxin-Related Hemolytic Uremic Syndrome.
Journal: Journal of the American Society of Nephrology : JASN
Published: March 01, 2024
Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.
Journal: Journal of the American Society of Nephrology : JASN
Published: November 08, 2022
Plasma cystatin C is a marker of renal glomerular injury in children treated with cisplatin or ifosfamide.
Journal: Pediatric blood & cancer
Published: July 10, 2020
CD49d/CD29-integrin controls the accumulation of plasmacytoid dendritic cells into the CNS during neuroinflammation.
Journal: European journal of immunology
Published: January 04, 2019
Quality of life in adolescents with chronic kidney disease who initiate haemodialysis treatment.
Journal: BMC nephrology
Published: June 15, 2018
Patient and transplant outcome in infants starting renal replacement therapy before 2 years of age.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 06, 2017
Treatment and outcome of congenital nephrotic syndrome.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 13, 2017
Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.
Journal: Pediatric nephrology (Berlin, Germany)
Published: June 27, 2017
Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumab.
Journal: Clinical immunology (Orlando, Fla.)
Published: March 17, 2017
Last Updated: 09/26/2026